Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioMark Diagnostics Inc C.BUX

Alternate Symbol(s):  BMKDF

BioMark Diagnostics Inc. is a liquid biopsy company. The Company is developing a molecular diagnostics technology platform, which leverages the power of metabolomics and machine learning algorithms to bring new cancer diagnostics to market and improve cancer prognosis by allowing physicians to detect carcinomas in the pre-symptomatic stages. The technology can also be used for measuring response to treatment and potentially for serial monitoring of cancer survivors. Its cancer diagnostics technology platform leverages Omics and machine learning with a focus on cancers that are hard to detect and treat. Its liquid biopsy assay detects Spermidine/spermine N-acetyltransferase 1 (SSAT1). SSAT1 is an enzyme with elevated levels in numerous cancers. It has also developed a new high powered liquid biopsy metabolic panel assay. The new metabolic assay is instrumental for early-stage diagnosis of lung cancer. The liquid biopsy metabolic panel has demonstrated clinical detections.


CSE:BUX - Post by User

Post by geodcanon Jan 25, 2024 8:17pm
58 Views
Post# 35846245

SH dropping the ball on supplying reliable info

SH dropping the ball on supplying reliable info
2024-01-19
Maula Bux (Rashid Ahmed)Director of Issuer
1,000
$290.00
1,218,900
SEDI
 
2023-12-29
Maula Bux (Rashid Ahmed)
1,032,261
$258,065.25
4,447,411
SEDI

2024-01-19
Maula Bux (Rashid Ahmed)Director of Issuer
1,000
$290.00
1,218,900
SEDI
 
2023-12-29
Maula Bux (Rashid Ahmed)
1,032,261
$258,065.25
4,447,411
SEDI
Check out the insider option and the math doesn't add up.  It does show Bux trading 1000 shares to support the artificially high shareprice but a couple of hundred dollar trade and his ownership drops by 3 million shares??

My bid still is active despite it not showing on this forum today.
<< Previous
Bullboard Posts
Next >>